Skip to main content

Table 1 Patients characteristics (N = 1001)

From: Increased risk of non-AIDS-defining cancers in Asian HIV-infected patients: a long-term cohort study

Median age (IQR), years

38 (31–48)

20–39

551 (55.0%)

40–49

239 (23.9%)

50–59

139 (13.9%)

60–69

56 (5.6%)

≥ 70

17 (1.7%)

Sex (male)

942 (94.1%)

Alcohol drinker

557 (55.6%)

Smoker

421 (42.1%)

Year of entry

 1997–2001

267 (26.7)

 2002–2006

331 (33.1)

 2007–2011

309 (30.9)

 2012–2015

94 (9.4)

HIV-related factors

 HIV risk group

  MSM

753 (75.2%)

  Heterosexuals

123 (12.3%)

  Blood transmissiona

99 (9.9%)

  Injection drug use

8 (0.8%)

  Unknown

18 (1.8%)

  Median CD4 (IQR), cells/μL

100 (30–184)

  CD4 < 200, cells/μL

777 (77.6)

  200–499

209 (20.9)

   ≥ 500

15 (1.5)

  Median HIV VL (IQR), copies/mL

63,000 (5400-310,000) (4.4–5.6)

  HIV VL < 400, copies/mL

166 (16.6)

  400–75,000

360 (36.0)

   > 75,000

475 (47.5)

  On antiretroviral therapy

312 (31.2)

  HBV infection alone

151 (15.1%)

  HCV infection

145 (14.5%)

  HBV and HCV co-infection

15 (1.5%)

Co-morbidities

 Hypertension

102 (10.2%)

 Dyslipidemia

129 (12.9%)

 Diabetes mellitus (uncomplicated)

80 (8.0%)

 Diabetes mellitus (end-organ damage)

32 (3.2%)

 Myocardial infarction

9 (0.9%)

 Congestive heart failure

15 (1.5%)

 Peripheral vascular disease

2 (0.2%)

 Cerebrovascular disease

16 (1.6%)

 Dementia

14 (1.4%)

 COPD

7 (0.7%)

 Connective tissue disease

2 (0.2%)

 Peptic ulcer disease

31 (3.1%)

 Chronic kidney disease

64 (6.4%)

 Hemiplegia

1 (0.1)

 Chronic liver disease

141 (14.1%)

 Mild

105 (10.5%)

 Moderate to severe

36 (3.6%)

  1. Note. aA total of 96% had hemophilia
  2. Abbreviations: HBV hepatitis B virus, HCV hepatitis C virus, HAART highly active anti-retroviral therapy, IQR interquartile range, MSM men who have sex with men, IDU injection drug users, VL viral load, COPD chronic obstructive pulmonary disease, NADCs non-AIDS-defining cancers